By Target

Development of COX-2 Inhibitors for GI and Liver Diseases Development of H2 Receptor Blockers for Gastrointestinal Diseases Development of Proton Pump Inhibitors for Gastrointestinal Diseases Development of ClC-2 Activators for Gastrointestinal Diseases Development of Guanylate Cyclase-C Agonists for GI Diseases Development of NHE Inhibitors for GI and Liver Diseases Development of JAK Inhibitors for IBD Development of Phosphodiesterase Inhibitors for GI and Liver Diseases Development of Antiviral Therapy Drug Development for Liver Disease Targeting Cells Targeting Physiological Processes Drug Development for Liver Disease Targeting Mitochondria Drug Development for Liver Disease Targeting Epidermal Growth Factor Receptor Drug Development for Liver Disease Targeting Epigenetics Drug Development for Liver Disease Targeting Prohibitin Gut Microbial-Based Drug Development Services for Liver Disease By Molecule Type By Research Phase